Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Health Protocols

Idiopathic Pulmonary Fibrosis

References

Agackiran Y, Gul H, Gunay E, Akyurek N, Memis L, Gunay S, . . . Ide T. The efficiency of proanthocyanidin in an experimental pulmonary fibrosis model: comparison with taurine. Inflammation. Aug 2012;35(4):1402-1410.

Akgedik R, Akgedik S, Karamanli H, Uysal S, Bozkurt B, Ozol D, . . . Yildirim Z. Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats. Inflammation. Oct 2012;35(5):1732-1741.

AMR. Taurine - monograph. Alternative medicine review: a journal of clinical therapeutic. Feb 2001;6(1):78-82.

Anand David AV, Arulmoli R, Parasuraman S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacognosy reviews. Jul-Dec 2016;10(20):84-89.

Aryal S, Nathan SD. An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis. Expert opinion on emerging drugs. May 2 2018.

Atkins CP, Gilbert D, Brockwell C, Robinson S, Wilson AM. Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases. Sarcoidosis, vasculitis, and diffuse lung diseases: official journal of WASOG. Aug 1 2016;33(2):130-138.

Atreya S, Kumar G, Datta SS. Gabapentin for Chronic Refractory Cancer Cough. Indian journal of palliative care. Jan-Mar 2016;22(1):94-96.

Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, . . . Kudoh S. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine. May 1 2005;171(9):1040-1047.

Baker EJ, Miles EA, Burdge GC, Yaqoob P, Calder PC. Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Progress in lipid research. Oct 2016;64:30-56.

Bando M. Pirfenidone: Clinical trials and clinical practice in patients with idiopathic pulmonary fibrosis. Respiratory investigation. Sep 2016;54(5):298-304.

Bese NS, Munzuroglu F, Uslu B, Arbak S, Yesiladali G, Sut N, . . . Ober A. Vitamin E protects against the development of radiation-induced pulmonary fibrosis in rats. Clinical oncology (Royal College of Radiologists (Great Britain)). May 2007;19(4):260-264.

Bickelhaupt S, Erbel C, Timke C, Wirkner U, Dadrich M, Flechsig P, . . . Huber PE. Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis. J Natl Cancer Inst. Aug 1 2017;109(8).

Blaisdell RJ, Schiedt MJ, Giri SN. Dietary supplementation with taurine and niacin prevents the increase in lung collagen cross-links in the multidose bleomycin hamster model of pulmonary fibrosis. Journal of biochemical toxicology. Apr 1994;9(2):79-86.

Boerma M, Roberto KA, Hauer-Jensen M. Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. International journal of radiation oncology, biology, physics. Sep 1 2008;72(1):170-177.

Bonella F, Kreuter M, Hagmeyer L, Neurohr C, Keller C, Kohlhaeufl MJ, . . . Prasse A. Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis. Respiration. 2016;92(2):98-106.

Buschhausen L, Kamm M, Arns W, Schulze-Lohoff E, Weber M. [Successful treatment of a severe case of idiopathic pulmonary fibrosis with rapamycin]. Med Klin (Munich). Mar 15 2005;100(3):161-164.

Caminati A, Cassandro R, Torre O, Harari S. Severe idiopathic pulmonary fibrosis: what can be done? European respiratory review: an official journal of the European Respiratory Society. Sep 30 2017;26(145).

Castelino FV. Lipids and eicosanoids in fibrosis: emerging targets for therapy. Curr Opin Rheumatol. Nov 2012;24(6):649-655.

Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, Ayres J, . . . Hopkins PM. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology (Carlton, Vic.). Oct 2014;19(7):1013-1018.

Chang W, Wei K, Ho L, Berry GJ, Jacobs SS, Chang CH, Rosen GD. A critical role for the mTORC2 pathway in lung fibrosis. PloS one. 2014;9(8):e106155.

Chen L, Zhao W. Apigenin protects against bleomycin-induced lung fibrosis in rats. Experimental and therapeutic medicine. Jan 2016;11(1):230-234.

Chen S, Cui G, Peng C, Lavin MF, Sun X, Zhang E, . . . Shao H. Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem Cell Research & Therapy. April 19 2018;9(1):110.

Chen XH, Sun RS, Hu JM, Mo ZY, Yang ZF, Jin GY, . . . Zhong NS. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice. Clin Exp Pharmacol Physiol. Feb 2009;36(2):146-153.

Choi SM, Jang AH, Kim H, Lee KH, Kim YW. Metformin Reduces Bleomycin-induced Pulmonary Fibrosis in Mice. Journal of Korean medical science. Sep 2016;31(9):1419-1425.

Chu X, Wei X, Lu S, He P. Autotaxin-LPA receptor axis in the pathogenesis of lung diseases. Int J Clin Exp Med. 2015;8(10):17117-17122.

Collard HR, Anstrom KJ, Schwarz MI, Zisman DA. Sildenafil improves walk distance in idiopathic pulmonary fibrosis. Chest. Mar 2007;131(3):897-899.

Costabel U, Albera C, Bradford WZ, Hormel P, King TE, Jr., Noble PW, . . . du Bois RM. Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis. Sarcoidosis, vasculitis, and diffuse lung diseases: official journal of WASOG. Oct 20 2014;31(3):198-205.

Cottin V, Bergot E, Bourdin A, Cadranel J, Camus P, Crestani B, . . . Cordier JF. Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey. ERJ open research. Oct 2015;1(2).

Day BJ. Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal. Feb 2008;10(2):355-370.

Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. Oct 1999;17(10):3283-3290.

Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, . . . Montanari M. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. Nov 24 2005;353(21):2229-2242.

Desai O, Winkler J, Minasyan M, Herzog EL. The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis. Front Med (Lausanne). 2018;5:43.

Drakopanagiotakis F, Wujak L, Wygrecka M, Markart P. Biomarkers in idiopathic pulmonary fibrosis. Matrix biology: journal of the International Society for Matrix Biology. Jan 31 2018.

Eduard Gorina LR, Ganesh Raghu, et al. . PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients . . European Respiratory Journal 2017 50: OA3400; DOI: 10.1183/1393003.congress-2017.OA3400 *Phase 2 result of Pamrevlumab. 2017.

Entzian P, Gerlach C, Gerdes J, Schlaak M, Zabel P. [Pentoxifylline inhibits experimental bleomycin-induced fibrosing alveolitis]. Pneumologie (Stuttgart, Germany). Apr 1997;51(4):375-380.

Entzian P, Schlaak M, Seitzer U, Acil Y, Ernst M, Zabel P. Pentoxifylline inhibits the fibrogenic activity of pleural effusions and transforming growth factor-beta. Mediators of inflammation. 1997;6(2):119-126.

Fagone E, Conte E, Gili E, Fruciano M, Pistorio MP, Lo Furno D, . . . Vancheri C. Resveratrol inhibits transforming growth factor-beta-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration. Experimental lung research. Apr 2011;37(3):162-174.

Failla M, Genovese T, Mazzon E, Gili E, Muia C, Sortino M, . . . Vancheri C. Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Respiratory research. Nov 21 2006;7:137.

Fastres A, Felice F, Roels E, Moermans C, Corhay JL, Bureau F, . . . Guiot J. The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies. International journal of molecular sciences. Dec 16 2017;18(12).

FDA. U.S. Food and Drug Administration. The Drug Development Process: Step 3: Clinical Research. https://www.fda.gov/ForPatients/Approvals/Drugs/ucm405622.htm. Last updated 1/4/2018. Accessed 5/3/2018.

Ferrara G, Luppi F, Birring SS, Cerri S, Caminati A, Skold M, Kreuter M. Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions. European respiratory review: an official journal of the European Respiratory Society. Mar 31 2018;27(147).

Fois AG, Paliogiannis P, Sotgia S, Mangoni AA, Zinellu E, Pirina P, . . . Zinellu A. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respiratory research. Mar 27 2018;19(1):51.

Frangogiannis NG. Fibroblast—Extracellular Matrix Interactions in Tissue Fibrosis. Current pathobiology reports. Mar 2016;4(1):11-18.

Gao L, Tang H, He H, Liu J, Mao J, Ji H, . . . Wu T. Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats. Frontiers in pharmacology. 2015;6:215.

Gamad N, Malik S, Suchal K, Vasisht S, Tomar A, Arava S, . . . Bhatia J. Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. Jan 2018;97:1544-1553.

Garcia FA, Reboucas JF, Balbino TQ, da Silva TG, de Carvalho-Junior CH, Cerqueira GS, . . . Viana GS. Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase. Journal of inflammation (London, England). 2015;12:33.

Gharaee-Kermani M, Hu B, Thannickal VJ, Phan SH, Gyetko MR. Current and emerging drugs for idiopathic pulmonary fibrosis. Expert opinion on emerging drugs. Nov 2007;12(4):627-646.

Ghebre YT, Raghu G. Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs. American journal of respiratory and critical care medicine. Jun 15 2016;193(12):1345-1352.

Ghebremariam YT, Cooke JP, Gerhart W, Griego C, Brower JB, Doyle-Eisele M, . . . Rosen GD. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis. Journal of translational medicine. Aug 1 2015;13:249.

Giri SN, Blaisdell R, Rucker RB, Wang Q, Hyde DM. Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary supplementation with taurine and niacin: biochemical mechanisms. Environ Health Perspect. Dec 1994;102 Suppl 10:137-147.

Glassberg MK, Minkiewicz J, Toonkel RL, Simonet ES, Rubio GA, DiFede D, . . . Hare JM. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial. Chest. May 2017;151(5):971-981.

Goa KL, Sorkin EM. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Drugs. Sep 1993;46(3):409-427.

Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-kappaB in mice. International immunopharmacology. Oct 2014;22(2):498-504.

Gouda MM, Prabhu A, Bhandary YP. Curcumin alleviates IL-17A-mediated p53-PAI-1 expression in bleomycin-induced alveolar basal epithelial cells. Journal of cellular biochemistry. Feb 2018;119(2):2222-2230.

Grant WB, Bhattoa HP, Boucher BJ. Seasonal variations of U.S. mortality rates: Roles of solar ultraviolet-B doses, vitamin D, gene exp ression, and infections. The Journal of steroid biochemistry and molecular biology. Oct 2017;173:5-12.

Gurujeyalakshmi G, Hollinger MA, Giri SN. Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis. American journal of respiratory cell and molecular biology. Mar 1998;18(3):334-342.

Gurujeyalakshmi G, Wang Y, Giri SN. Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin. Nitric Oxide. Aug 2000a;4(4):399-411.

Gurujeyalakshmi G, Wang Y, Giri SN. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice. The Journal of pharmacology and experimental therapeutics. Apr 2000b;293(1):82-90.

Haddad P, Kalaghchi B, Amouzegar-Hashemi F. Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: a phase II clinical trial. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. Dec 2005;77(3):324-326.

Han MK, Bach DS, Hagan PG, Yow E, Flaherty KR, Toews GB, . . . Martinez FJ. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. Chest. Jun 2013;143(6):1699-1708.

Hemmati AA, Rezaie A, Darabpour P. Preventive effects of pomegranate seed extract on bleomycin-induced pulmonary fibrosis in rat. Jundishapur journal of natural pharmaceutical products. Spring 2013;8(2):76-80.

Hewitt RJ, Molyneaux PL. The respiratory microbiome in idiopathic pulmonary fibrosis. Annals of translational medicine. Jun 2017;5(12):250.

Hoe E, Nathanielsz J, Toh ZQ, Spry L, Marimla R, Balloch A, . . . Licciardi PV. Anti-Inflammatory Effects of Vitamin D on Human Immune Cells in the Context of Bacterial Infection. Nutrients. Dec 12 2016;8(12).

Hughes G, Toellner H, Morris H, Leonard C, Chaudhuri N. Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis. Journal of clinical medicine. Sep 2 2016;5(9).

Impellizzeri D, Talero E, Siracusa R, Alcaide A, Cordaro M, Maria Zubelia J, . . . Motilva V. Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice. The British journal of nutrition. Sep 28 2015;114(6):853-865.

Institute of Medicine. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary. Washington (DC): National Academies Press (US); 2012. Appendix B, The Clinical Trials Process. 2012.

Izumo T, Kondo M, Nagai A. Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis. The European respiratory journal. Dec 2009;34(6):1444-1451.

Jackson RM, Glassberg MK, Ramos CF, Bejarano PA, Butrous G, Gomez-Marin O. Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis. Lung. Apr 2010;188(2):115-123.

Jiang C, Huang H, Liu J, Wang Y, Lu Z, Xu Z. Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials. PloS one. 2012;7(10):e47024.

Jiang F, Yang Y, Xue L, Li B, Zhang Z. 1α,25-dihydroxyvitamin D3 Attenuates TGF-β-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial–Mesenchymal Transition. Nutrients. 2017;9(9):980.

Jiang S, Li T, Yang Z, Yi W, Di S, Sun Y, . . . Yang Y. AMPK orchestrates an elaborate cascade protecting tissue from fibrosis and aging. Ageing research reviews. Sep 2017;38:18-27.

Jin X, Dai H, Ding K, Xu X, Pang B, Wang C. Rapamycin attenuates bleomycin-induced pulmonary fibrosis in rats and the expression of metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 in lung tissue. Chin Med J (Engl). 2014;127(7):1304-1309.

Justice JN, Nambiar AM, Tchkonia T, LeBrasseur NK, Pascual R, Hashmi SK, . . . Kirkland JL. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine. Jan 4 2019.

Kaidar-Person O, Marks LB, Jones EL. Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer. The breast journal. Apr 23 2018.

Kalayarasan S, Sriram N, Soumyakrishnan S, Sudhandiran G. Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fibrosis through the involvement of protease activated receptor-2. Toxicology and applied pharmacology. Sep 1 2013;271(2):184-195.

Kalayarasan S, Sriram N, Sudhandiran G. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta. Life sciences. Jun 6 2008;82(23-24):1142-1153.

Kao HF, Chang-Chien PW, Chang WT, Yeh TM, Wang JY. Propolis inhibits TGF-beta1-induced epithelial-mesenchymal transition in human alveolar epithelial cells via PPARgamma activation. International immunopharmacology. Mar 2013;15(3):565-574.

Kaya V, Yazkan R, Yildirim M, Doguc DK, Suren D, Bozkurt KK, . . . Yalcin AY. The relation of radiation-induced pulmonary fibrosis with stress and the efficiency of antioxidant treatment: an experimental study. Med Sci Monit. Feb 21 2014;20:290-296.

Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Frontiers in pharmacology. 2014;5.

Kennedy JI, Jr., Chandler DB, Fulmer JD, Wert MB, Grizzle WE. Dietary fish oil inhibits bleomycin-induced pulmonary fibrosis in the rat. Experimental lung research. Mar 1989;15(2):315-329.

Kirkland JL, Tchkonia T, Zhu Y, Niedernhofer LJ, Robbins PD. The Clinical Potential of Senolytic Drugs. J Am Geriatr Soc. Oct 2017;65(10):2297-2301.

Kistler KD, Nalysnyk L, Rotella P, Esser D. Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature. BMC pulmonary medicine. Aug 16 2014;14:139.

Kreuter M, Ehlers-Tenenbaum S, Palmowski K, Bruhwyler J, Oltmanns U, Muley T, . . . Herth FJ. Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis. PloS one. 2016;11(3):e0151425.

Kumar D, Yalamanchali S, New J, Parsel S, New N, Holcomb A, . . . Thomas SM. Development and Characterization of an In Vitro Model for Radiation-Induced Fibrosis. Radiation research. Mar 2018;189(3):326-336.

Kuwano K, Araya J, Hara H, Minagawa S, Takasaka N, Ito S, . . . Nakayama K. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Respiratory investigation. Nov 2016;54(6):397-406.

Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. BMC pharmacology & toxicology. Apr 2 2018;19(1):13.

Ladeiras-Lopes R, Fontes-Carvalho R, Bettencourt N, Sampaio F, Gama V, Leite-Moreira A. Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease. Expert opinion on therapeutic targets. Jul 2015;19(7):869-877.

Larki-Harchegani A, Hemmati AA, Arzi A, Ghafurian-Boroojerdnia M, Shabib S, Zadkarami MR, Esmaeilzadeh S. Evaluation of the Effects of Caffeic Acid Phenethyl Ester on Prostaglandin E2 and Two Key Cytokines Involved in Bleomycin-induced Pulmonary Fibrosis. Iranian journal of basic medical sciences. Jul 2013;16(7):850-857.

Larki A, Hemmati AA, Arzi A, Borujerdnia MG, Esmaeilzadeh S, Zad Karami MR. Regulatory effect of caffeic acid phenethyl ester on type I collagen and interferon-gamma in bleomycin-induced pulmonary fibrosis in rat. Res Pharm Sci. Oct 2013;8(4):243-252.

Lawrence J, Nho R. The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis. International journal of molecular sciences. Mar 8 2018;19(3).

Lawrenz J, Herndon B, Kamal A, Mehrer A, Dim DC, Baidoo C, . . . Baybutt RC. Dietary Flaxseed Oil Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats. Pulmonary medicine. 2012;2012:457031.

Lee CM, Lee DH, Ahn BK, Hwang JJ, Yoon H, Shin CM, . . . Kim N. Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis. J Neurogastroenterol Motil. Jul 30 2016;22(3):444-451.

Lee JG, Shim S, Kim MJ, Myung JK, Jang WS, Bae CH, . . . Park S. Pentoxifylline Regulates Plasminogen Activator Inhibitor-1 Expression and Protein Kinase A Phosphorylation in Radiation-Induced Lung Fibrosis. BioMed research international. 2017;2017:1279280.

Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, . . . Collard HR. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine. Dec 15 2011;184(12):1390-1394.

Lehmann M, Korfei M, Mutze K, Klee S, Skronska-Wasek W, Alsafadi HN, . . . Konigshoff M. Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo. The European respiratory journal. Aug 2017;50(2).

Lelli D, Sahebkar A, Johnston TP, Pedone C. Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacological research: the official journal of the Italian Pharmacological Society. Jan 2017;115:133-148.

Li F, Han F, Li H, Zhang J, Qiao X, Shi J, . . . Liu X. Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice. Mol Immunol. Oct 2017;90:11-21.

Li H, Hao Y, Zhang H, Ying W, Li D, Ge Y, . . . Jin S. Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice. Sci Rep. May 3 2017;7:46754.

Li H, Hua J, Guo CX, Wang WX, Wang BJ, Yang DL, . . . Lu YP. Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban. Jun 2016;36(3):372-376.

Li H, Tan G, Tong L, Han P, Zhang F, Liu B, Sun X. Pentoxifylline inhibits pulmonary inflammation induced by infrarenal aorticcross-clamping dependent of adenosine receptor A2A. American journal of translational research. 2016;8(5):2210-2221.

Li X, Yue S, Luo Z. Mesenchymal stem cells in idiopathic pulmonary fibrosis. Oncotarget. Nov 24 2017;8(60):102600-102616.

Lindell KO, Kavalieratos D, Gibson KF, Tycon L, Rosenzweig M. The palliative care needs of patients with idiopathic pulmonary fibrosis: A qualitative study of patients and family caregivers. Heart & lung : the journal of critical care. Jan - Feb 2017;46(1):24-29.

Liu D, Gong L, Zhu H, Pu S, Wu Y, Zhang W, Huang G. Curcumin Inhibits Transforming Growth Factor beta Induced Differentiation of Mouse Lung Fibroblasts to Myofibroblasts. Frontiers in pharmacology. 2016;7:419.

Liu J, Chen F, Wei Z, Qiu M, Li Z, Dan H, . . . Jiang L. Evaluating the efficacy of pentoxifylline in the treatment of oral submucous fibrosis: A meta-analysis. Oral diseases. Jul 24 2017.

Liu M, Gou S, Chen HT, Chen ZH. [The Study of the Effect and Mechanism of Glucagon Like Peptide-1 in Bleomycin-induced Pulmonary Fibrosis in Mice]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition. Jul 2017;48(4):509-514.

Lois K, Kassi E, Prokopiou M, Chrousos GP. Adrenal Androgens and Aging. In: De Groot LJ, Chrousos G, Dungan K, et al., eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.

Lopera DE, Naranjo TW, Hidalgo JM, Echeverri L, Patino JH, Moreno AR, . . . Cano LE. Pentoxifylline immunomodulation in the treatment of experimental chronic pulmonary paracoccidioidomycosis. Fibrogenesis & tissue repair. 2015;8:10.

Magazine R, Shetty R, Goneppanavar U, Mohapatra AK. Idiopathic clubbing confined to lower limb digits and idiopathic pulmonary fibrosis: an unusual association. Case reports in pulmonology. 2012;2012:684285.

Malouf MA, Hopkins P, Snell G, Glanville AR. An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis. Respirology (Carlton, Vic.). Jul 2011;16(5):776-783.

Margaritopoulos GA, Vasarmidi E, Antoniou KM. Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy. Core evidence. 2016;11:11-22.

Markart P, Luboeinski T, Korfei M, Schmidt R, Wygrecka M, Mahavadi P, . . . Ruppert C. Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. Antioxid Redox Signal. Feb 2009;11(2):227-240.

Martinez FJ, de Andrade JA, Anstrom KJ, King TE, Jr., Raghu G. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. May 29 2014;370(22):2093-2101.

McCarty MF, O'Keefe JH, DiNicolantonio JJ. Pentoxifylline for vascular health: a brief review of the literature. Open heart. 2016;3(1):e000365. McCormack PL. Nintedanib: first global approval. Drugs. Jan 2015;75(1):129-139.

Mendoza-Milla C, Valero Jimenez A, Rangel C, Lozano A, Morales V, Becerril C, . . . Selman M. Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosis. The European respiratory journal. Nov 2013;42(5):1309-1321.

Mercer PF, Woodcock HV, Eley JD, Plate M, Sulikowski MG, Durrenberger PF, . . . Chambers RC. Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. Thorax. Aug 2016;71(8):701-711.

Mermigkis C, Bouloukaki I, Antoniou K, Papadogiannis G, Giannarakis I, Varouchakis G, . . . Schiza SE. Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis. Sleep & breathing = Schlaf & Atmung. Mar 2015;19(1):385-391.

Mojiri-Forushani H, Hemmati AA, Dehghani MA, Malayeri AR, Pour HH. Effects of herbal extracts and compounds and pharmacological agents on pulmonary fibrosis in animal models: a review. Journal of integrative medicine. Nov 2017;15(6):433-441.

Murtha LA, Schuliga MJ, Mabotuwana NS, Hardy SA, Waters DW, Burgess JK, . . . Boyle AJ. The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis. Front Physiol. 2017;8.

Myllarniemi M, Kaarteenaho R. Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine. European clinical respiratory journal. 2015;2.

Nagai A, Matsumiya H, Hayashi M, Yasui S, Okamoto H, Konno K. Effects of nicotinamide and niacin on bleomycin-induced acute injury and subsequent fibrosis in hamster lungs. Experimental lung research. Jul-Aug 1994;20(4):263-281.

Nakamura T, Matsushima M, Hayashi Y, Shibasaki M, Imaizumi K, Hashimoto N, . . . Kawabe T. Attenuation of transforming growth factor-beta-stimulated collagen production in fibroblasts by quercetin-induced heme oxygenase-1. American journal of respiratory cell and molecular biology. May 2011;44(5):614-620.

Naranjo TW, Lopera DE, Diaz-Granados LR, Duque JJ, Restrepo AM, Cano LE. Combined itraconazole-pentoxifylline treatment promptly reduces lung fibrosis induced by chronic pulmonary paracoccidioidomycosis in mice. Pulmonary pharmacology & therapeutics. Feb 2011;24(1):81-91.

National Heart, Lung, and Blood Institute. Idiopathic Pulmonary Fibrosis. Treatment. https://www.nhlbi.nih.gov/health-topics/idiopathic-pulmonary-fibrosis. Accessed 5/3/2018.

Nesti L, Natali A. Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data. Nutrition, metabolism, and cardiovascular diseases : NMCD. Aug 2017;27(8):657-669.

Nho RS, Hergert P. IPF fibroblasts are desensitized to type I collagen matrix-induced cell death by suppressing low autophagy via aberrant Akt/mTOR kinases. PloS one. 2014;9(4):e94616.

Nicolson GL. Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements. Integrative medicine (Encinitas, Calif.). Aug 2014;13(4):35-43.

NIH. National Institute on Aging. Clinical Trials: Benefits, Risks, and Safety. https://www.nia.nih.gov/health/clinical-trials-benefits-risks-and-safety. 5/17/2017. Accessed 5/3/2018.

Nikbakht J, Hemmati AA, Arzi A, Mansouri MT, Rezaie A, Ghafourian M. Protective effect of gallic acid against bleomycin-induced pulmonary fibrosis in rats. Pharmacological reports: PR. Dec 2015;67(6):1061-1067.

Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, . . . du Bois RM. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. May 21 2011;377(9779):1760-1769.

O'Neill CA, Giri SN. Biochemical mechanisms for the attenuation of bleomycin-induced lung fibrosis by treatment with niacin in hamsters: the role of NAD and ATP. Experimental lung research. Jan-Feb 1994;20(1):41-56.

Oldham JM, Noth I, Martinez FJ. Pharmacogenetics and interstitial lung disease. Current opinion in pulmonary medicine. Sep 2016;22(5):456-465.

Olson AL, Swigris JJ, Raghu G, Brown KK. Seasonal Variation: Mortality From Pulmonary Fibrosis Is Greatest in the Winter. Chest. Jul 2009;136(1):16-22.

Ozyurt H, Sogut S, Yildirim Z, Kart L, Iraz M, Armutcu F, . . . Akyol O. Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clinica chimica acta; international journal of clinical chemistry. Jan 2004;339(1-2):65-75.

Pan Y, Fu H, Kong Q, Xiao Y, Shou Q, Chen H, . . . Chen M. Prevention of pulmonary fibrosis with salvianolic acid a by inducing fibroblast cell cycle arrest and promoting apoptosis. Journal of ethnopharmacology. Sep 29 2014;155(3):1589-1596.

Patel AS, Lin L, Geyer A, Haspel JA, An CH, Cao J, . . . Morse D. Autophagy in idiopathic pulmonary fibrosis. PloS one. 2012;7(7):e41394.

Plantier L, Cazes A, Dinh-Xuan AT, Bancal C, Marchand-Adam S, Crestani B. Physiology of the lung in idiopathic pulmonary fibrosis. European respiratory review: an official journal of the European Respiratory Society. Mar 31 2018;27(147).

Punithavathi D, Venkatesan N, Babu M. Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats. British journal of pharmacology. Sep 2000;131(2):169-172.

Queen BL, Tollefsbol TO. Polyphenols and aging. Current aging science. Feb 2010;3(1):34-42.

Raghu G, Anstrom KJ, King TE, Jr., Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. May 24 2012;366(21):1968-1977.

Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, . . . Pellegrini CA. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. The European respiratory journal. Jan 2006;27(1):136-142.

Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, . . . Schunemann HJ. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. American journal of respiratory and critical care medicine. Jul 15 2015;192(2):e3-19.

Rangarajan S, Bone NB, Zmijewska AA, Jiang S, Park DW, Bernard K, . . . Zmijewski JW. Metformin reverses established lung fibrosis in a bleomycin model. Nature medicine. Jul 2 2018.

Ren ZX, Yu HB, Li JS, Shen JL, Li JK, Luo S. [Inhibitory effect of Panax notoginseng saponins on alveolar epithelial to mesenchymal transition]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. Dec 2015;40(23):4667-4671.

Rong L, Wu J, Wang W, Zhao RP, Xu XW, Hu D. Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT). European review for medical and pharmacological sciences. May 2016;20(10):2144-2150.

Rushworth GF, Megson IL. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacology & therapeutics. Feb 2014;141(2):150-159.

Salvatore M, Ishikawa G, Padilla M. Is It Idiopathic Pulmonary Fibrosis or Not? Journal of the American Board of Family Medicine: JABFM. Jan-Feb 2018;31(1):151-162.

Sato N, Takasaka N, Yoshida M, Tsubouchi K, Minagawa S, Araya J, . . . Kuwano K. Metformin attenuates lung fibrosis development via NOX4 suppression. Respiratory research. Aug 30 2016;17(1):107.

Samaras N, Papadopoulou MA, Samaras D, Ongaro F. Off-label use of hormones as an antiaging strategy: a review. Clin Interv Aging. 2014;9:1175-1186.

Sarkar M, Madabhavi I, Niranjan N, Dogra M. Auscultation of the respiratory system. Annals of thoracic medicine. Jul-Sep 2015;10(3):158-168.

Sarkar M, Mahesh DM, Madabhavi I. Digital clubbing. Lung India: official organ of Indian Chest Society. Oct 2012;29(4):354-362.

Sathiyamoorthy G, Sehgal S, Ashton RW. Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis. Southern medical journal. Jun 2017;110(6):393-398.

Scelfo C, Caminati A, Harari S. Recent advances in managing idiopathic pulmonary fibrosis. F1000Research. 2017;6:2052.

Schafer MJ, White TA, Iijima K, Haak AJ, Ligresti G, Atkinson EJ, . . . LeBrasseur NK. Cellular senescence mediates fibrotic pulmonary disease. Nature communications. Feb 23 2017;8:14532.

Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Idiopathic pulmonary fibrosis: pathogenesis and management. Respiratory research. Feb 22 2018;19(1):32.

Shao X, Li M, Luo C, Wang YY, Lu YY, Feng S, . . . Chen JH. Effects of rapamycin against paraquat-induced pulmonary fibrosis in mice. Journal of Zhejiang University. Science. B. Jan 2015;16(1):52-61.

Sharif R. Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines. The American journal of managed care. Jul 2017;23(11 Suppl):S176-s182.

Shaw J, Marshall T, Morris H, Hayton C, Chaudhuri N. Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age. J Thorac Dis. Nov 2017;9(11):4700-4707.

Shi Y, Liu T, Yao L, Xing Y, Zhao X, Fu J, Xue X. Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system. Sci Rep. Jun 12 2017;7(1):3312.

Smith MR, Gangireddy SR, Narala VR, Hogaboam CM, Standiford TJ, Christensen PJ, . . . Reddy RC. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. American journal of physiology. Lung cellular and molecular physiology. May 2010;298(5):L616-625.

Sriram N, Kalayarasan S, Sudhandiran G. Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulmonary pharmacology & therapeutics. Jun 2009;22(3):221-236.

Srivastava S. Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders. Clin Transl Med. Dec 2016;5(1):25.

Sternlicht MD, Wirkner U, Bickelhaupt S, Lopez Perez R, Tietz A, Lipson KE, . . . Huber PE. Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab. Respiratory research. Jan 18 2018;19(1):14.

Sun T, Liu J, Zhao de W. Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Medicine. May 2016;95(19):e3629.

Suzuki T, Tada Y, Gladson S, Nishimura R, Shimomura I, Karasawa S, . . . West J. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respiratory research. Oct 16 2017;18(1):177.

Tang H, Gao L, Mao J, He H, Liu J, Cai X, . . . Wu T. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-kappaB and TGF-beta1/Smad-2/-3 pathways. Cell stress & chaperones. Mar 2016;21(2):239-249.

Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, . . . Nukiwa T. Pirfenidone in idiopathic pulmonary fibrosis. The European respiratory journal. Apr 2010;35(4):821-829.

Tomassetti S, Wells AU, Costabel U, Cavazza A, Colby TV, Rossi G, . . . Poletti V. Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. Apr 1 2016;193(7):745-752.

Tsukioka T, Takemura S, Minamiyama Y, Mizuguchi S, Toda M, Okada S. Attenuation of Bleomycin-Induced Pulmonary Fibrosis in Rats with S-Allyl Cysteine. Molecules. Mar 29 2017;22(4).

Tzilas V, Tzouvelekis A, Chrysikos S, Papiris S, Bouros D. Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”. Front Med (Lausanne). 2017;4.

Vainshelboim B. Exercise training in idiopathic pulmonary fibrosis: is it of benefit? Breathe (Sheffield, England). Jun 2016;12(2):130-138.

Vassiliadis E, Barascuk N, Karsdal MA. Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development. Am J Transl Res. 2013;5(1):1-14.

Veith C, Drent M, Bast A, van Schooten FJ, Boots AW. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin. Toxicology and applied pharmacology. Dec 1 2017;336:40-48.

Verma R, Kushwah L, Gohel D, Patel M, Marvania T, Balakrishnan S. Evaluating the Ameliorative Potential of Quercetin against the Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats. Pulmonary medicine. 2013;2013:921724.

Vyshedskiy A, Murphy R. Crackle Pitch Rises Progressively during Inspiration in Pneumonia, CHF, and IPF Patients. Pulmonary medicine. 2012;2012:240160.

Wang QJ, Giri SN, Hyde DM, Nakashima JM, Javadi I. Niacin attenuates bleomycin-induced lung fibrosis in the hamster. Journal of biochemical toxicology. Spring 1990;5(1):13-22.

Wang Y, Cao R, Wei B, Chai X, Sun D, Guan Y, Liu XM. Diallyl disulfide inhibits proliferation and transdifferentiation of lung fibroblasts through induction of cyclooxygenase and synthesis of prostaglandin E(2). Molecular and cellular biochemistry. Aug 2014;393(1-2):77-87.

Wecht S, Rojas M. Mesenchymal stem cells in the treatment of chronic lung disease. Respirology (Carlton, Vic.). Nov 2016;21(8):1366-1375.

Wen WX, Lee SY, Siang R, Koh RY. Repurposing Pentoxifylline for the Treatment of Fibrosis: An Overview. Advances in therapy. Jun 2017;34(6):1245-1269.

Whitehouse MW. Anti-TNF-alpha therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs. Inflammopharmacology. 2004;12(3):223-227.

Wu J, Ling C, He H, Sun G, Gu Z, Ji B. [Effect of compound panax notoginsenoside granules on TGF-beta1/Smads signaling pathway in rats with bleomycin-induced pulmonary fibrosis]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. Sep 2013;29(9):927-930.

Xu M, Deng B, Chow YL, Zhao ZZ, Hu B. Effects of curcumin in treatment of experimental pulmonary fibrosis: a comparison with hydrocortisone. Journal of ethnopharmacology. Jun 13 2007;112(2):292-299.

Yan B, Ma Z, Shi S, Hu Y, Ma T, Rong G, Yang J. Sulforaphane prevents bleomycininduced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2related factor2 activation. Molecular medicine reports. Jun 2017;15(6):4005-4014.

Yanai H, Shteinberg A, Porat Z, Budovsky A, Braiman A, Ziesche R, Fraifeld VE. Cellular senescence-like features of lung fibroblasts derived from idiopathic pulmonary fibrosis patients. Aging (Albany NY). Sep 2015;7(9):664-672.

Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, . . . Okajima F. 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiological reports. Dec 2015;3(12).

Yin K, Agrawal DK. Vitamin D and inflammatory diseases. Journal of inflammation research. 2014;7:69-87.

Zank DC, Bueno M, Mora AL, Rojas M. Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics. Frontiers in medicine. 2018;5:10.

Zeng Z, Cheng S, Chen H, Li Q, Hu Y, Wang Q, . . . Wang J. Activation and overexpression of Sirt1 attenuates lung fibrosis via P300. Biochemical and biophysical research communications. May 13 2017;486(4):1021-1026.

Zhan H, Huang F, Ma W, Zhao Z, Zhang H, Zhang C. Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of Caveolin-1 and TGF-beta1 Signal Pathway. Biological & pharmaceutical bulletin. 2016;39(8):1284-1292.

Zhang C, Yin X, Zhang J, Ao Q, Gu Y, Liu Y. Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: A case report. Experimental and therapeutic medicine. May 2017;13(5):1922-1926.

Zhang D, Liu B, Cao B, Wei F, Yu X, Li GF, . . . Wang PL. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-beta1/Smad2 pathways and overexpression of NOX4. International immunopharmacology. Jul 2017;48:67-75.

Zhang DP, Qiu H, Zhuang Y, Meng FQ. [The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. Mar 2007;30(3):197-201.

Zhang L, Duan Y, Zhang TP, Huang XL, Li BZ, Ye DQ, Wang J. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study. International journal of rheumatic diseases. Aug 2017;20(8):1002-1008.

Zhang L, Zhang C, Dong F, Song Q, Chi F, Liu L, . . . Che C. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis. BMC pulmonary medicine. Nov 3 2016;16(1):137.

Zhang X, Huang H, Chang H, Jin X. Magnolol reduces bleomycin-induced rodent lung fibrosis. Int J Clin Exp Med. 2015;8(9):15450-15457.

Zhang Z, Yu X, Fang X, Liang A, Yu Z, Gu P, . . . Yi X. Preventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis. Sci Rep. Dec 2 2015;5:17638.

Zhao CJ, Niu JZ, Wang JF, Zhou G, Tang BH. [Effects of curcumin on bleomycin-induced damages in pulmonary functions in rats]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. Jun 2008;33(12):1434-1438.

Zhao H, Chan-Li Y, Collins SL, Zhang Y, Hallowell RW, Mitzner W, Horton MR. Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis. BMC pulmonary medicine. Apr 18 2014;14:64.

Zhou CC, Yang X, Hua X, Liu J, Fan MB, Li GQ, . . . Miao CY. Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing. British journal of pharmacology. Aug 2016;173(15):2352-2368.

Zhou XM, Huang MM, He CC, Li JX. Inhibitory effects of citrus extracts on the experimental pulmonary fibrosis. Journal of ethnopharmacology. Oct 29 2009;126(1):143-148.

Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, . . . Kirkland JL. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. Aug 2015;14(4):644-658.

Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med. Aug 12 2010;363(7):620-628.

;